期刊文献+

抑癌基因p53第5~8外显子突变与喉鳞癌关系的研究 被引量:2

Experimental Studies on Exons 5-8 of p53 Gene Mutation in Laryn geal Squamous Cell Carcinoma
暂未订购
导出
摘要 为探讨抑癌基因p53基因突变与喉鳞癌之间的关系,应用聚合酶链反应单链构象多态性分析(PCR-SSCP)银染系统,检测60例喉鳞癌新鲜组织中抑癌基因p53基因第5~8外显子的突变情况。结果:60例喉鳞癌组织中,发生47例第5~8外显子迁移率异常的SSCP区带,总的突变率为78.3%。SSCP阳性病例在外显子5、6、7、8中的突变率由高到低依次为Exon 5、Exon 7、Exon 8、Exon 6。提示第5、7外显子有可能是喉鳞癌发病相关的致癌因素选择性攻击的关键部位。 This study was designed to detect the point mutations of exons 58 of p53 gene in laryngeal squamous cell carcinoma (LSCC) and analyze their relationship. The detection of fresh tumor samples from LSCC patients was performed using silver staining PCRSSCP method. From among 60 patient samples , 47 were positive in SSCP. Mutation rate was 78.3% (47/60). The results showed that the prevalence of p53 mutations in LSCC subjected to silver staining PCRSS CP test were 50% (30/60) in exon 5, 11.67%(7/60) in exon 6, 41.6%(25/60) in exo n 7, and 25%(15/60) in exon 8. The majority of the mutations were found in exon 5 and exon 7. Exon 5 and exon 7 of p53 gene may be the mutation hotspot in LSCC; t hey may be the critical position easily attacked by some carcinogen factors relati ng to LSCC.
出处 《华西医科大学学报》 CSCD 2000年第3期295-297,共3页 Journal of West China University of Medical Sciences
基金 国家自然科学基金(批准号39500160) 美国中华医学基金会(CMB)专项基金
关键词 喉鳞癌 P53基因 银染PCR-SSCP 基因突变 Laryngeal neoplasms PCR-SSCP p53 gene Mutation
  • 相关文献

参考文献3

共引文献16

同被引文献19

  • 1王吉喆,关超,王寿忱,陈滨,孙家良,季文樾.Survivin蛋白在喉鳞状细胞癌中的表达及意义[J].临床耳鼻咽喉科杂志,2005,19(6):247-249. 被引量:8
  • 2罗克强,王直中,王娜亚,张小伯,杨继生.p53在喉鳞状细胞癌及癌旁组织中的表达与生物学行为的关系及意义[J].临床耳鼻咽喉科杂志,2005,19(9):405-408. 被引量:13
  • 3SCHOLNICK S B,SUN P C,SHAW M E,et al. Frequent loss of heterozygosity for Rb, TP53, and chromosome arm 3p,but not NME1 in squamous cell carcinomas of the supraglottic larynx[J]. Cancer, 1994, 73; 2472-2480.
  • 4KOCH W M,BRENNAN J A,ZAHURAK M,et al. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma[J]. J Natl Can Inst, 1996,88 : 1580- 1586.
  • 5BRENNAN J A,MAO L,HRUBAN R H,et al. Molecular assessment of histopathological staging in squamous cell carcinoma of the head and neck[J]. N Engl J Med,1995,132:429-435.
  • 6VIEBA R, BILBAO J, ISPIZUA A, et al. p53 and Cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx[J]. Laryngoscope, 2003,113 : 167 -172.
  • 7THOMPSON C B. Apoptosis in the pathogenesis and treatment of disease [J]. Science, 1995, 267: 1456 - 1462.
  • 8ALTIERI D C. Survivin, versatile modulation of cell division and apoptosis in cancer[J]. Oncogene, 2003, 22:8581-8589.
  • 9THOMADAKIH, SCORILASA. BCL2 familyofapoptosis-related genes: functions and clinical implications in cancer[J]. Crit Rev Clin Lab Sci, 2006,43..1-67.
  • 10DONG Y, SUI L, WATANABE Y, et al. Survivin expression in laryngeal squamous cell carcinomas and its prognostic implication[J]. Anticancer Res, 2002, 22:2377-2383.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部